Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III Trial JCOG0505 - Kitagawa, R; Katsumata, N; Shibata, T (J Clin Oncol, 2015)
cited 2022Apr5 [Internet]